Does Lipitor (atorvastatin) raise AST and ALT in the liver?
Yes. Like other statins, Lipitor can raise liver enzyme levels in blood tests, especially the aminotransferases AST (aspartate aminotransferase) and ALT (often shown as “ALT,” not “ADL”). These lab increases usually reflect mild liver irritation rather than direct liver injury, and many people never develop clinically significant liver disease.
How common is it, and does it mean liver damage?
Mild, temporary elevations in AST/ALT can occur during statin therapy. Serious liver injury is uncommon. Clinicians typically monitor AST/ALT after starting or changing the dose and may hold the drug if enzyme levels become substantially elevated or persist.
What do “AST” and “ADL” mean on liver blood tests?
AST is an enzyme measured on liver function panels. ALT is the other main aminotransferase used to monitor liver inflammation/injury. “ADL” is not a standard liver test abbreviation; many people mean ALT when they ask about “ADL.” If you share the exact lab names from your report, I can help interpret them.
When should someone call a doctor?
People should seek medical advice promptly if AST/ALT elevations come with symptoms such as yellowing of the skin/eyes (jaundice), dark urine, severe fatigue, right upper abdominal pain, persistent vomiting, or unusual bleeding/bruising. If your AST/ALT values are elevated, your prescriber may recheck labs and consider dose adjustment or stopping the medication.
Is there a difference between AST and ALT changes on statins?
Both AST and ALT can rise, but ALT is generally more specific to liver. The pattern and magnitude matter: small increases are usually managed with monitoring, while larger or persistent increases may trigger more evaluation.
Would switching statins or stopping help?
Often, if liver enzymes rise, clinicians first recheck labs and review other contributors (alcohol use, viral hepatitis, other medications, supplements). If elevations are significant or keep worsening, they may lower the dose, switch to another statin, or stop therapy depending on the risk-benefit.
Sources
No sources were provided with your question, and I don’t have access to external data in this chat.